Details of the Drug Reposition

General Information of This Drug (ID: DMHRYX6)

• Drug Name: SLV-323 (DMHRYX6)

Information on Drug Reposition of This Drug

3 Discontinued in Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Gastric motility disorder	DISXTE5N	DA21	Discontinued in Phase 1	[1]
Irritable bowel syndrome	DIS27206	DD91.0	Discontinued in Phase 1	[1]
Chemotherapy-induced nausea	DIS24TP9	MD90	Discontinued in Phase 1	[1]

References

• [1] Emerging drugs for chemotherapy-induced emesis. Expert Opin Emerg Drugs. 2006 Mar;11(1):137-51.